BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 38588555)

  • 21. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
    Hou W; Bonkovsky HL
    World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of Extracellular Vesicles on the Progression and Metastasis of Hepatocellular Carcinoma.
    Seay TW; Suo Z
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
    Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D
    World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapy-induced modulation of extracellular vesicles in hepatocellular carcinoma.
    Yeung CLS; Yam JWP
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):1088-1101. PubMed ID: 35158067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complex interactions between microRNAs and hepatitis B/C viruses.
    Fan HX; Tang H
    World J Gastroenterol; 2014 Oct; 20(37):13477-92. PubMed ID: 25309078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases.
    Ferro A; Saccu G; Mattivi S; Gaido A; Herrera Sanchez MB; Haque S; Silengo L; Altruda F; Durazzo M; Fagoonee S
    Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
    Yu SJ; Kim YJ
    World J Gastroenterol; 2014 Sep; 20(34):12039-44. PubMed ID: 25232241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
    Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).
    Lv X; Ye G; Zhang X; Huang T
    Medicine (Baltimore); 2017 Sep; 96(38):e8106. PubMed ID: 28930859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma.
    Zhang MH; Yuan YF; Liu LJ; Wei YX; Yin WY; Zheng LZ; Tang YY; Lv Z; Zhu F
    World J Gastroenterol; 2023 Aug; 29(31):4706-4735. PubMed ID: 37664153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of small extracellular vesicles in the development, diagnosis and possible treatment strategies for hepatocellular carcinoma (Review).
    Yang S; Wang J; Wang S; Zhou A; Zhao G; Li P
    Int J Oncol; 2022 Aug; 61(2):. PubMed ID: 35674180
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.
    Van Hees S; Michielsen P; Vanwolleghem T
    World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma-A Review.
    Oura K; Morishita A; Masaki T
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33171811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extracellular Vesicles in Hepatocellular Carcinoma: Progress and Challenges in the Translation from the Laboratory to Clinic.
    Yan R; Chen H; Selaru FM
    Medicina (Kaunas); 2023 Sep; 59(9):. PubMed ID: 37763719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.
    Szabo G; Momen-Heravi F
    Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):455-466. PubMed ID: 28634412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.
    Tornesello ML; Buonaguro L; Izzo F; Buonaguro FM
    Oncotarget; 2016 May; 7(18):25087-102. PubMed ID: 26943571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanoquercetin and Extracellular Vesicles as Potential Anticancer Therapeutics in Hepatocellular Carcinoma.
    Raghav A; Jeong GB
    Cells; 2024 Apr; 13(7):. PubMed ID: 38607076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular Vesicle-Related Non-Coding RNAs in Hepatocellular Carcinoma: An Overview.
    Augello G; Cusimano A; Cervello M; Cusimano A
    Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extracellular Vesicles Contribute to Viral-Induced Hepatocellular Carcinoma: Understanding Their Involvement in Viral Hepatitis and Their Potential as Biomarkers for Early Hepatocellular Carcinoma Detection.
    Tahir F; Farooq M; Malik MA; Manzoor S
    Viral Immunol; 2024 Apr; 37(3):159-166. PubMed ID: 38588555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma.
    Yang N; Li S; Li G; Zhang S; Tang X; Ni S; Jian X; Xu C; Zhu J; Lu M
    Oncotarget; 2017 Jan; 8(2):3683-3695. PubMed ID: 27713136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.